Cargando…
Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity
The efficacy of the intranasally (i.n.) delivered live attenuated influenza vaccine (LAIV) is variable and, in some seasons, suboptimal. In this study, we report that LAIV exhibits cross-protective efficacy in mice, potentially associated with cellular immunity as opposed to antigen-specific antibod...
Autores principales: | Roy, Sreeja, Williams, Clare M, Pardo, Julian, Wijesundara, Danushka K, Furuya, Yoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563680/ https://www.ncbi.nlm.nih.gov/pubmed/32825218 http://dx.doi.org/10.3390/vaccines8030459 |
Ejemplares similares
-
Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020) -
Fear of Influenza Resurgence amid COVID-19 Pandemic: Need for Effective Flu Vaccine Still Exists
por: Wijesundara, Danushka K., et al.
Publicado: (2021) -
LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza
por: Williams, Clare M, et al.
Publicado: (2022) -
Detrimental impact of allergic airway disease on live attenuated influenza vaccine
por: Roy, Sreeja, et al.
Publicado: (2021) -
Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses
por: Tomusange, Khamis, et al.
Publicado: (2016)